Form 8-K - Current report:
SEC Accession No. 0001193125-24-227950
Filing Date
2024-09-27
Accepted
2024-09-27 16:05:52
Documents
13
Period of Report
2024-09-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d707178d8k.htm   iXBRL 8-K 30389
  Complete submission text file 0001193125-24-227950.txt   154447

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aura-20240923.xsd EX-101.SCH 2862
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aura-20240923_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aura-20240923_pre.xml EX-101.PRE 11266
15 EXTRACTED XBRL INSTANCE DOCUMENT d707178d8k_htm.xml XML 3624
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40971 | Film No.: 241334882
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)